Latest Administration News

Vitrafy Life Sciences reported a $32.7 million loss for FY25, driven by investments in its next-generation cryopreservation platform following a $35 million IPO and a $4.8 million government grant. The company is progressing commercialization efforts with key partnerships in human and animal health.

Telix Pharmaceuticals has recast its historical financials from AUD to USD to better reflect its US-centric revenue streams and reports increased operating expenditure tied to recent acquisitions and growth initiatives.

Noxopharm’s Sofra™ technology shows promising results in collaboration with US biotech Tezcat Biosciences, advancing targeted drug delivery for cancer and inflammatory diseases.

Universal Biosensors reported a 44% increase in net loss to A$10.45 million for H1 2025, alongside an 11% revenue decline, raising serious going concern doubts. The company is pursuing an A$8.5 million senior secured loan and equity raise to sustain operations.

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.

ActivePort Group Ltd has announced a fully underwritten entitlement offer to raise approximately $2.5 million, issuing new shares and options to existing shareholders and underwriters. The capital raise aims to fund business growth and repay loans but will dilute non-participating shareholders significantly.

Activeport Group Ltd has announced a fully underwritten rights issue to raise up to $2.5 million, offering shareholders discounted shares and free options to accelerate growth initiatives.

Receivers and Managers have been appointed over Bowen Coking Coal and its subsidiaries following voluntary administration, as the company explores sale and recapitalisation options while maintaining operations.

The ASX has suspended the securities of Antilles Gold, Heramed, and Syntara due to missed periodic report deadlines, signaling compliance concerns ahead of potential reinstatement.

Infinity Lithium secures a three-month extension for its San José lithium project amid regulatory challenges, while reshuffling its board to pivot towards Australian precious metals.

Alcoa Corporation reported a solid $164 million net income for Q2 2025 amid strategic portfolio shifts including a new joint venture in Spain and the sale of its Saudi Arabia stake. The company navigated tariff challenges and resumed a key smelter restart after a power outage delay.

EMU NL has advanced its Yataga Copper Project to drill-ready status with a maiden drilling campaign planned, while assessing monetization options for its Badja Gold Project amid ongoing corporate governance and privacy issues.